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Aim: It is known that desflurane and propofol protect liver tissue via different mechanisms. The aim of this study was to compare the
protective effects of these 2 agents against hepatic ischemia-reperfusion injury.
Materials and methods: Rats were randomly divided into 2 groups: ischemia and ischemia-reperfusion. Each group was further divided
into 3 subgroups: ketamine, desflurane, and propofol. Thirty minutes after anesthetics were administered, the rats were subjected to 45
min of hepatic ischemia and 4 h of reperfusion. Blood samples and liver tissues were obtained in order to assess serum tumor necrosis
factor alpha (TNF-α), interleukin-1β (IL-1β), and malondialdehyde levels and for histologic examination.
Results: The postischemic serum IL-1β levels were significantly higher with propofol than with ketamine (P = 0.014). In the postischemic
period, in the ischemia-desflurane group, TNF-α levels were significantly lower than in the ischemia-propofol (P = 0.009). The number
of polymorphonuclear leukocytes was the lowest in the ketamine group in the postischemic period (P < 0.01).
Conclusion: In order to reach a definitive judgment, studies with a larger number of subjects are necessary.
Key words: Liver, ischemia-reperfusion injury, desflurane, propofol

1. Introduction
The interruption of hepatic inflow is a common procedure
conducted during liver transplantation, resectional surgery,
and trauma surgery (1). However, after a period of hepatic
ischemia, blood flow and oxygen supply are reestablished;
reperfusion enhances the injury caused by ischemia. This
phenomenon, known as ischemia-reperfusion (IR) injury,
directly affects liver viability (2).
Reperfusion after ischemic injury triggers the activation
of several transcription factors, including nuclear factor
(NF)-κB, which in turn alters the transcription of multiple
genes associated with the inflammatory response, including
intracellular adhesion molecule-1, interleukin (IL)-1β,
IL-8, and tumor necrosis factor (TNF)-α. The release of
reactive oxygen species from activated Kupffer cells leads
to the generation of end products of lipid peroxidation,
such as malondialdehyde (MDA) (3,4).
Desflurane and propofol are frequently used in general
anesthesia. Previous studies have shown that both of these
drugs protect against IR injury of the liver via different
mechanisms (5–8).
* Correspondence: aycatas@yahoo.com
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We designed the present study to determine which of
the 2 drugs has a greater effect on the changes in systemic
cytokine levels (IL-1β and TNF-α), MDA levels, and liver
histopathology in a rat model of hepatic IR.
2. Materials and methods
All experimental protocols were approved by the Animal
Research Committee at Gazi University, Ankara, Turkey.
All animals were maintained in accordance with the
recommendations of the National Institutes of Health
Guidelines for the Care and Use of Laboratory Animals.
Thirty adult male Wistar rats weighing 250–330 g each
were maintained on a 12-h night/day cycle and allowed free
access to food and water at all times until the experiments.
All rats were anesthetized with 50 mg/kg intramuscular
(IM) ketamine (Ketalar®; 1 mL = 50 mg; Pfizer, İstanbul,
Turkey) and 0.01 mg atropine (Atropin Sülfat®; 0.5 mg/
mL; Biofarma, İstanbul, Turkey). They were placed on an
electric heating pad under a warming light, and the body
temperatures were continuously monitored using a rectal
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thermometer. Their temperature was maintained at 37 °C.
After tracheal intubation with a 16-gauge (G) intravenous
(IV) cannula, the animals’ lungs were artificially ventilated
with a rodent model ventilator (Inspira ASV; Harvard
Apparatus, Hollistone, MA, USA). The ventilatory rate was
set at 80 strokes/min with a tidal volume of 10 mL/kg. The
tail vein was cannulated with a 24-G IV cannula for drug
administration and hydration. After a local anesthetic
effect was achieved using 1% lidocaine HCl (Jetmonal®;
2%; Adeka, Samsun, Turkey), a midline abdominal incision
was performed. The abdominal aorta was identified, and
a 26-G IV cannula (Ar-Es IV Neo, İzmir, Turkey) was
inserted to enable direct measurement of the mean arterial
blood pressure (MABP), heart rate (HR), and blood gas
analysis.
The rats were randomly divided into 2 groups: ischemia
(I) and ischemia-reperfusion (IR). Each group was further
divided into 3 subgroups of 5 rats each: a ketamine group
(Group I-K and Group IR-K), receiving intramuscular
50 mg/kg ketamine injections every 30 min; a desflurane
group (Suprane®; 240 mL; Baxter, İstanbul, Turkey)
(Group I-D and Group IR-D), in which 6% desflurane
was administered with oxygen via anesthesia apparatus;
and a propofol group (Propofol®; 1%; Fresenius Kabi AB,
Leipzig, Germany) (Group I-P and Group IR-P), receiving
hourly 20 mg/kg IV infusion via a pump (Eczacıbaşı Baxter
Healthcare volumetric infusion pump; İstanbul, Turkey).
No muscle relaxants were given to the animals to ensure
that the depth of general anesthesia was observable. Thirty
minutes after the administration of the anesthetic drugs,
the liver was exposed and the ligamentous attachments of
the left lateral and median lobes were carefully divided.
The left lateral and median lobes were freed. The portal
circulation of these lobes was dissected, and the portal
vein and the hepatic artery supplying the median and left
lateral lobes were blocked with an atraumatic vascular
clamp (Harvard Apparatus). Intestinal venous congestion
was prevented by retaining portal and arterial inflow
with venous outflow in caudate and right lateral lobes.
This procedure resulted in the induction of ischemia
in approximately 65%–70% of the liver. After 45 min of
ischemia, the clamp was removed. The rats in Groups I-K,
I-D, and I-P were sacrificed by hemorrhage at the end
of the ischemic period. The rats in Groups IR-K, IR-D,
and IR-P were subjected to hepatic ischemia followed by
reperfusion for 4 h, and were also sacrificed at the end of
the reperfusion period. Blood samples were withdrawn
and were centrifuged at 3000 rpm for 5 min (CentronicBL; JP Selecta, Barcelona, Spain). Following the collection
of supernatant liquid, the samples were stored at –80 °C
until assayed for the measurement of TNF-α, IL-1β, and
MDA. Additionally, liver samples from the left lateral
and median hepatic lobes were collected and fixed with

10% formalin and embedded in paraffin for histologic
examination.
Serum TNF-α and IL-1β levels were determined in a
96-well microplate, using a commercial enzyme-linked
immunosorbent assay kit (BioSource International, Inc.,
Camarillo, CA, USA) according to the manufacturer’s
guidelines. All samples were tested in duplicate. The plate
was read on an ELx800 automated microplate reader (BioTek Instruments, Inc., Winooski, VT, USA) at 450 nm. The
concentrations of TNF-α and IL-1β were compared with
the standard curve and expressed as pg/mL. The minimal
detectable protein concentration was 8–16 pg/mL.
MDA concentration, a product of lipid peroxidation,
was also measured. Tissue samples from the liver were
homogenized with a Virsonic 100 (Virtis Company Inc.,
Gardiner, NY, USA) ultrasonic homogenizer. Briefly, 0.1
mL of homogenate was mixed with 0.1 mL of 8.1% sodium
dodecyl sulfate, 0.75%; 0.8% thiobarbituric acid; and 0.3 mL
of distilled water and kept in a boiling water bath for 60 min.
After cooling, 0.5 mL of distilled water and 2.5 mL of 15:1
(v/v) n-butanol/pyridine were added. After centrifugation
at 4000 rpm, the absorbance of the supernatant at 532 nm
was measured with spectrophotometry (Shimadzu Corp.,
Tokyo, Japan) against a calibration curve obtained from
a MDA standard. The results were expressed as nmol/L
protein.
For morphological assessment of hepatic injury and
polymorphonuclear leukocytes (PNLs), adhesions were
performed by a pathologist blinded to tissue sections
prepared at 6-µm intervals and stained with hematoxylineosin. Sections were evaluated at 200× magnification for
severity of injury and graded using an ordinal scale as
follows: grade 0, minimal or no evidence of injury; grade
1, mild injury consisting of cytoplasmic vacuolation
and focal nuclear pyknosis; grade 2, moderate to severe
injury with extensive nuclear pyknosis, cytoplasmic
hypereosinophilia, and loss of intercellular borders; and
grade 3, severe necrosis with disintegration of hepatic
cords, hemorrhage, and PNL infiltration.
2.1. Statistical analysis
All data were expressed as mean ± standard deviation (SD).
Comparisons between multiple groups were performed
using the Kruskal–Wallis test. When a difference was
detected, specific differences were identified using the
Bonferroni corrected Mann–Whitney U test. SPSS 12.0
for Windows (SPSS Inc., Chicago, IL, USA) was used to
complete all the analyses, and P < 0.05 was considered
statistically significant.
3. Results
Throughout the experiment, the HR ranged between
115 and 324 bpm for all groups. The MABP levels were
comparable among the groups. There were no significant
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IL-1β (pg/ml)

However, postreperfusion liver slices showed more severe
Grade 2 injury for both desflurane (40%) and propofol
(60%) administration than postischemic slices. However,
this worsening of the hepatic injury was statistically
insignificant (P = 0.262). None of the groups had a Grade
3 hepatic injury (Table 2).
300
250
200
150
100
50
0

Ketamine

Desflurane

Propofol

Postischemia

Postreperfusion

Figure 1. Serum IL-1β concentrations in rats postischemia and
postreperfusion. Each bar represents the mean ± SD. *: P < 0.05
versus Group I-K.

TNF - α (pg/ml)

differences in HR among the groups; however, the HR
levels of Group IR-D in the fifth minute of the ischemic
period were lower than those of Group IR-K (P = 0.009)
(Table 1). Additionally, pH levels and PaCO2 tensions were
comparable, and no significant differences were found
within the groups.
In order to determine whether serum cytokine levels
correlated with tissue injury, IL-1β and TNF-α levels were
measured. As shown in Figure 1, the highest levels of
IL-1β were found in Group I-P among ischemia groups.
The levels of IL-1β in Group I-P were significantly higher
than those of Group I-K (P = 0.014). Postreperfusion
measurements showed an increase with all 3 agents of the
groups. While the highest levels of IL-1β were observed in
Group I-P at the end of I, the lowest level was recorded for
Group IR-P at the end of R.
The serum TNF-α findings for all groups are shown in
Figure 2. The TNF-α levels of Group I-D were significantly
lower than those of Group I-P (P = 0.009). Although
there were no significant differences in postreperfusion
measurements, the lowest TNF-α levels were found in
Group IR-D.
The liver contents of lipid peroxidation by-product
MDA levels can be seen in Figure 3. Although the
maximum values of tissue MDA levels were found in
Group IR-P, and the lowest values in Group IR-K, there
were no significant differences in liver MDA contents
among any of the 3 groups (P > 0.05).
Liver biopsy specimens were obtained after ischemia
and 4 h of reperfusion (Figure 4). The assessment of the
liver sections from Group I-D showed Grade 1 (80%) or 2
(20%) hepatic injury, which was the same as in Group I-P.

300
300
300
300
300
300
300
300
300
300

Ketamine

Desflurane

Propofol

Postischemia

Postreperfusion

Figure 2. Serum TNF-α concentrations in rats postischemia and
postreperfusion. Each bar represents the mean ± SD. &: P < 0.01
versus Group I-D.

Reperfusion

Ischemia

Preischemia

Table 1. Time course of changes in HR in experimental groups.
Group I-K
(n = 5)

Group I-D
(n = 5)

Group I-P
(n = 5)

Group IR-K
(n = 5)

Group IR-D
(n = 5)

Group IR-P
(n = 5)

30

252.40 ± 42.26

207.60 ± 46.16

208.20 ± 32.93

250.20 ± 42.07

189.20 ± 24.92

235.40 ± 49.60

15

242.80 ± 36.64

192.20 ± 36.96

224.00 ± 25.19

252.60 ± 46.74

194.00 ± 23.92

222.40 ± 43.90

0

245.40 ± 57.84

199.40 ± 48.13

210.80 ± 15.32

256.00 ± 49.18

182.80 ± 23.12

217.00 ± 58.08

5

268.80 ± 45.92

186.80 ± 44.74

216.00 ± 44.06

265.00 ± 35.16

179.40 ± 25.56*

212.60 ± 63.83

15

250.40 ± 48.09

192.60 ± 43.51

208.00 ± 35.41

264.80 ± 30.25

194.00 ± 16.00

221.80 ± 76.38

45

242.60 ± 52.13

183.20 ± 54.66

195.80 ± 34.38

244.00 ± 34.54

193.00 ± 21.59

201.00 ± 44.64

5

225.40 ± 24.79

189.40 ± 34.72

205.20 ± 52.19

15

230.20 ± 39.88

185.20 ± 36.22

197.80 ± 50.85

30

220.00 ± 56.09

182.00 ± 38.81

182.40 ± 48.34

60

205.40 ± 60.11

183.40 ± 38.70

162.80 ± 33.49

Data are expressed as mean ± SD. *: P < 0.05 vs. Group IR-K.
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Table 2. Histopathologic liver changes.
Severity of hepatic injury
G0 (n)

G1 (n)

G2 (n)

G3 (n)

Postischemia
Ketamine

1

4

Desflurane

4

1

Propofol

4

1

Postreperfusion
3

1

Desflurane

Ketamine

1

3

2

Propofol

2

3

G: grade. See text for further details.
900
MDA (mmol/L)

800

Ketamine

Desflurane

Propofol

700
600
500
400
300
200
100
0

Postischemia

Postreperfusion

Figure 3. MDA levels in liver. Each bar represents the mean ±
SD. There was no statistical significance among the groups.

As seen in Table 3, the number of PNLs was the lowest
in Group I-K (P < 0.01). Although there was an increase
in PNLs after the R period in all 3 groups, it was not
statistically significant (P > 0.05).
4. Discussion
In our study, we compared the protective effects of
desflurane and propofol using a hepatic ischemiareperfusion model in rats. We concluded that the protective
effects of desflurane are stronger because its effect acts
through TNF-α, which was detected at lower levels both at
the end of ischemia and reperfusion.
Tumor necrosis factor-α, IL-1β, and MDA levels
were used to evaluate IR injury in various tissues in both
clinical and experimental studies (1,6–15). During hepatic
ischemia, the increase in TNF-α levels remains detectable,
both in the plasma and liver tissue, until the late phase of
reperfusion (10). In a study using rats, with a partial hepatic
ischemia model, following IR, a significant increase in the
plasma TNF-α and macrophage inflammatory protein-2

levels was reported (11,12). Similarly, we also observed a
significant increase in the plasma TNF-α and IL-1 levels
after reperfusion.
In animal experiments, increasing TNF-α levels caused
both hepatic and pulmonary damage (13). Thus, TNF-α
not only acts locally but also systemically, resulting in
functional impairment in other organ systems. Studies
on liver allograft rejections strongly suggested that TNF-α
and IL-1 play a role in the early phase of rejection and that
the specific inhibition of cytokines can prevent allograft
rejection (14).
A study with a rat hepatic IR model indicated that
TNF-α antibody had a protective effect against IR,
and alanine aminotransferase (ALT) and MDA levels
decreased significantly compared to the control group,
in which no TNF-α antibody was administered (15).
In other studies with similar models, the IL-1 receptor
blockade was shown to decrease tissue damage and thus
decrease mortality (16,17). This evidence suggests that
the anesthetic agent that greatly prevents the increase in
TNF-α, IL-1, and MDA levels will have the best protective
effects against tissue damage.
Desflurane is almost immune to biological degradation,
with a 0.02% calculated metabolism ratio, and is less
soluble in plasma and tissues. Thus, it has almost no risk of
hepatotoxicity (5) and is preferred in hepatobiliary surgery
as it has a protective effect on the hepatic blood flow and
causes less toxicity (18). Furthermore, pretreatment with
desflurane limits the NF-κB activation, which is stimulated
by TNF-α, leading to a cellular protective effect (6). The
extent of myocardial infarct was reported to decrease in
dogs with cardiac IR that were pretreated with desflurane
(19). In a similar study in human umbilical vein cells,
the expression of the adhesion molecules, stimulated by
TNF-α, and the prevention of neutrophil adhesion was
reported (20). In our study, when desflurane was used,
TNF-α levels were lowest at the end of the reperfusion.
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PNL

Table 3. Count of PNLs.
Group I-K
(n = 5)

Group I-D
(n = 5)

Group I-P
(n = 5)

Group IR-K
(n = 5)

Group IR-D
(n = 5)

Group IR-P
(n = 5)

6.00 ± 1.58

13.80 ± 4.76

12.40 ± 5.41

14.00 ± 9.82

15.80 ± 5.98

19.80 ± 6.80

Data are expressed as mean ± SD.

G1

G0

G2

Figure 4. Hepatic histopathology following IR. G0: Normal
hepatic histology. G1: Vacuolar degeneration and low counts
of apoptotic cells. G2: Loss of cytoplasmic membrane, diffuse
eosinophilia with many apoptotic cells. The liver sections were
prepared and stained with hematoxylin and eosin, 400×.

However, we did not observe a comparable decrease in
IL-1 levels.
Propofol is an intravenous anesthetic agent. Its
2,6-diisopropylphenol component is chemically similar to
other radical scavengers, such as butylene hydroxytoluene,
from the phenol hydroxyl group, and vitamin E. This
suggests that propofol also has a radical-scavenging
property (21).
In both in vivo and in vitro studies, propofol has
been reported to have a protective effect against lipid
peroxidation in many tissues (22–24). In addition, studies
with rat tissue cultures indicate that propofol protects
the liver tissue from peroxidation (25,26). It inhibits
inducible nitric oxide synthase over-expression, which
activates its antiinflammatory effects in the liver (27).
According to recent studies, propofol has antioxidant
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and antiinflammatory properties (28,29). Contrary
to these studies supporting its antioxidant properties,
an in vitro study of rat liver tissue samples showed that
propofol has no protective effects against IR damage. This
is possibly because propofol and its lipid contents cannot
be metabolized in the damaged liver tissue, which results
in the accumulation of propofol (30). In our study, after
propofol administration, end-reperfusion TNF-α levels
were higher than those of both desflurane and ketamine.
This suggests a stronger cytokine response after propofol
administration, and a lack of hepatoprotective effect.
In a study similar to ours, which compared the
effect of desflurane and propofol-remifentanil (TIVA)
on postoperative renal and hepatic functions after right
hepatectomy in living donors, aspartate aminotransferase
and ALT levels increased in both groups, while total
bilirubin levels and the international normalized ratio,
which are associated with liver damage, were higher in the
TIVA group. Furthermore, in the TIVA group, creatinine
levels were high and the glomerular filtration rate was low.
In light of these results, desflurane is proposed as the best
choice during liver transplantation (18).
In conclusion, no significant differences were found
between the 2 agents in terms of the IL-1β and MDA levels
and histopathological examination. A difference was only
observed in the TNF-α levels, but this was attributed to the
small number of subjects. In order to reach a conclusion,
further studies should be conducted with a larger number
of subjects. In addition, in surgical interventions of long
duration, such as liver transplantation, propofol causes
an excessive lipid load. For this reason, we think that
desflurane use can be more advantageous in this type of
surgery.
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